News FocusCANCER

Encouraging Results for Second-Generation Antiangiogenesis Drugs

See allHide authors and affiliations

Science  27 May 2005:
Vol. 308, Issue 5726, pp. 1248-1249
DOI: 10.1126/science.308.5726.1248

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

The strategy of denying growing tumors a blood supply continues to show clinical promise as new and improved drugs move through the pipeline.